US 7855233
Citrate salt of Rasagiline
granted A61KA61K31/135A61K9/2013
Quick answer
US patent 7855233 (Citrate salt of Rasagiline) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/135, A61K9/2013, A61K9/2018, A61K9/2054